← Back to search
HBVTECH, L.L.C
GERMANTOWN, MD, 20874
UnclaimedClaim this profile (free)
Minority Owned
Prime contracting experience
3 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services National Institutes of Health | EVALUATING HBVZ10-BASED THERAPIED FOR CCCDNA CLEARANCE: VIROLOGICAL FOUNDATION AND SYNERGISTIC COMBINATIONS | — | $606,178 | Jul 13, 2026 | Aug 1, 2025 – Jul 31, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | SBIR PHASE II TOPIC 84 ENTITLED "ANTIVIRAL DRUGS TO CURE CHRONIC HEPATITIS B VIRUS INFECTION" | — | $1,549,999 | Apr 3, 2023 | Sep 1, 2022 – Aug 25, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | SBIR NIAID TOPIC 084: "ANTIVIRAL DRUGS TO CURE CHRONIC HEPATITIS B VIRUS INFECTION" | — | $299,868 | Nov 9, 2021 | Aug 19, 2020 – Oct 15, 2021 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Health and Human ServicesGov-sourced
Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.